The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Clarity on study types for messages in unbranded tools
-
For an unbranded tool, can you give a list of study types that might be permissible for disease messages (diagnosis and symptoms), therapeutic options messages and for class MOA messages?
Natalie Bourré
Marketing 4 Health Inc.
Medical Marketing Consultant, Medical Writer
nat@marketing4health.net -
For an unbranded tool, can you give a list of study types that might be permissible for disease messages (diagnosis and symptoms), therapeutic options messages and for class MOA messages?
Hi @natbourre
Please see Q&A 214. For anything discussing disease burdens, please also see our recent guidance document Guidance on the Presentation of Burdens of Disease in Advertising, specifically section 5.3.
